Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
AICAR for AMPK–Mitophagy Research
2026-08-19
AICAR provides a focused way to interrogate AMPK-linked energy metabolism regulation and mitochondrial quality control. This article translates sarcopenic-obesity findings into rigorous assay design, controls, and interpretation strategies.
-
Primidone Research: TRPM3, RIPK1 & ALS Workflows
2026-08-19
Primidone (Mysoline) supports a practical bridge from TRPM3 channel inhibition to RIPK1-centered neurodegeneration studies, with a separate biochemical workflow for hPON1 inhibition. This guide emphasizes concentration selection, assay controls, animal-model dosing, and troubleshooting for reproducible translational research.
-
Paclitaxel Workflows for Senescence-Targeted Cancer Research
2026-08-18
Paclitaxel (Taxol) provides a controllable microtubule-stress workflow for separating acute mitotic arrest from persistent chemotherapy-induced senescence. This guide translates a landmark breast cancer study into practical dosing, recovery, senolytic, imaging, and troubleshooting strategies for reproducible cancer research.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-08-18
The reference study developed a dendritic-cell delivery strategy that transported fluorescently labeled amikacin into granulomas in mice infected with Mycobacterium avium. Its findings support organism-directed antibiotic delivery as a preclinical approach for increasing local drug exposure while limiting detectable systemic exposure, although long-term efficacy and clinical translation remain unresolved.
-
KR-12–Cu(II) Binding: Theory Meets Experiment
2026-08-17
The 2024 Dalton Transactions study combines potentiometric titration, isothermal titration calorimetry, and GFN2-xTB/ALPB calculations to clarify how the LL-37-derived peptide KR-12 interacts with Cu(II). Its key contribution is a residue- and atom-level interpretation of a dynamic metal–peptide system, showing that backbone oxygen atoms dominate coordination while Asp26 and Arg29 help define favorable binding modes.
-
Bacitracin B1670: Practical Protocol and QC Guide
2026-08-17
Bacitracin B1670 is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide covers solution preparation, storage, assay controls, and interpretation boundaries; the material is for scientific research only and is not intended for diagnostic, clinical, or medical use.
-
Dual Luciferase Reporter Gene System for BMSC Studies
2026-08-16
Learn how a Dual Luciferase Reporter Gene System can test promoter activity and pathway responsiveness in BMSC osteogenesis research. This article connects the K1136 workflow with the MRF–FSHR–cAMP/PKA/CREB findings reported in a 2025 study while emphasizing normalization, controls, and assay limitations.
-
Deferasirox Fe3+ Chelate: From Iron to Myeloid Insight
2026-08-15
Deferasirox Fe3+ chelate offers translational researchers more than a model of iron binding. Interpreted alongside recent evidence connecting deferasirox to mitochondrial ROS, NF-κB, and stage-specific myeloid maturation, it becomes a useful tool for separating iron-removal biology from cell-state effects in beta-thalassemia, chronic anemia, and broader iron overload treatment research.
-
BV6 IAP Antagonist: Applied Research Workflows
2026-08-14
BV6 is a Smac-mimetic IAP antagonist for testing apoptosis, radiosensitization, chemotherapy response, and immune-cell cytotoxicity. This practical workflow connects concentration design with orthogonal cell-death assays while showing how recent RIPK3–MLKL findings can sharpen mechanistic interpretation.
-
Amyloid Beta-peptide (25-35) Workflow Guide
2026-08-14
Build reproducible neuronal and microglial injury assays with Amyloid Beta-peptide (25-35), from peptide handling through ROS, mitochondrial, viability, and inflammatory readouts. The workflow also connects Aβ25-35 exposure with the FLOT1–FOSL2–EphA2 pathway, supporting more informative Alzheimer’s disease neurotoxicity models.
-
4-Hydroxytamoxifen: Protocol and QC Guide
2026-08-13
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro and in vivo research workflows. It is unsuitable for protocols requiring ethanol or aqueous solubility, and solution storage should be minimized to support compound integrity and reproducibility.
-
NSP15 Screening Identifies Thymopentin and Oleuropein
2026-08-13
The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize thymopentin and oleuropein as candidate inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. Its main contribution is a computational workflow for targeting viral immune evasion, while its findings remain lead-generation evidence requiring biochemical, cellular, and in vivo validation.
-
ZNF263, ULK1, and Autophagy in ICC
2026-08-12
This study identifies ZNF263 as an enhancer-associated transcriptional regulator that promotes intrahepatic cholangiocarcinoma proliferation through the ULK1-autophagy axis. Its combination of clinical tissue analysis, genome-wide binding analysis, transcriptomics, reporter validation, and functional rescue provides a mechanistic framework for studying gene expression regulation in ICC.
-
LG 101506 and the Next Frontier of RXR Biology
2026-08-12
RXR modulation can connect nuclear receptor biology, tumor-cell state, and immune checkpoint research. This thought-leadership guide positions LG 101506 as a research tool for testing those connections without overstating what is currently known.
-
Duhuo Jisheng Decoction and the MAPK1/HMOX1 Axis
2026-08-11
This study identifies an acacetin-mediated MAPK1/HMOX1 pathway that connects mitophagy with pyroptosis in nucleus pulposus cells during intervertebral disc degeneration. Its staged chemical, cellular, mechanistic, and animal experiments suggest that Duhuo Jisheng decoction may protect disc tissue by restoring mitochondrial quality control and limiting inflammatory cell death.